Docusign faces sluggish revenue growth and margin contraction despite its dominant market position and expanded AI-driven solutions portfolio. DOCU's Q2 billings showed improvement, but full-year ...
Docusign is rated Buy with a $81 price target, offering 14% upside potential and market outperformance over the next 12 months. DOCU trades at a 25% discount to sector median P/E, despite exceptional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results